¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2022-07-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2022-07-07
±³À°ÀÏÀÚ : 2022-07-07
±³À°Àå¼Ò : ¼­¿ï¿Ã¸²ÇÈÆÄÅ©ÅÚ  
±³À°ÁÖÁ¦ : 2022³âµµ Á¦25Â÷ Çмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÌÇѳª
¿¬¶ôó : 02-401-1570  
À̸ÞÀÏ : kscm.office@gmail.com      
±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø 10¸¸¿ø, ÁØȸ¿ø 5¸¸¿ø, Æò»ýȸ¿ø 10¸¸¿ø, ´Üüȸ¿ø 10¸¸¿ø, ºñȸ¿ø 25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 09:00~09:30 Collection, transport, preparation, and storage of specimens for molecular methods (CLSI MM13, 2nd edition)  ¹Ú¼ºÇö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 09:30~10:00 Validation and verification of multiplex nucleic acid assays (CLSI MM17, 2nd edition)  È«Áø¿µ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 10:00~10:30 Laboratory detection, identification, and sensitivity testing of mycobacteria  À̱ÔÅÃ(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 10:30~11:00 Diagnostic performance and quality control of COVID-19 testing; molecular diagnosis and immunological diagnosis  È«±âÈ£(¿¬¼¼ÀÇ´ë) 
È޽Ġ07-07 ¿Ã¸²ÇǾÆȦ 11:00~12:00 Break / Exhibition / Social Activity  () 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 12:00~13:00 How IT tools and surveillance system could contribute to improve patient care?  Stéphanie Le Page(Global associate medical Director in bioMérieux) 
±âŸ 07-07 ¿Ã¸²ÇǾÆȦ 13:00~13:10 Opening Remarks  () 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 13:10~14:00 Implementing antimicrobial stewardship programs in Korea  ±è½Å¿ì(°æºÏÀÇ´ë) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 14:00~14:25 Syndromic testing for the diagnosis of respiratory tract infections in Japan  Hiromichi Suzuki(University of Tsukuba) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 14:25~14:50 Syndromic testing for the diagnosis of urogenital tract infections in Japan  Satoshi Takahashi(Sapporo Med. University) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 14:50~15:15 Multiplex detection of gastrointestinal pathogens in Korea  ¼Õ¿ëÇÐ(¾¾Á¨ÀÇ·áÀç´Ü) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 15:15~15:40 Rapid identification of pathogens and drug resistance genes associated bloodstream infection  ¹ÚÀçÇö(¼­¿ïÀÇ´ë) 
È޽Ġ07-07 ¿Ã¸²ÇǾÆȦ 15:40~15:50 Break / Exhibition  () 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 15:50~16:15 Diagnosis of sepsis: From blood culture to new biomarkers Young Ah Kim  ±è¿µ¾Æ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 16:15~16:40 Emerging technique for diagnosis of infection or resistance  ±èÅüö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 16:40~17:05 Expanded clinical use of MALDI-TOF in clinical microbiology Jae-Seok  ±èÀç¼®(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 07-07 ¿Ã¸²ÇǾÆȦ 17:05~17:30 Application of metagenomics in clinical aspect  À±ÀºÁ¤(Áúº´°ü¸®Ã») 
Åä·Ð 07-07 ¼­¿ïȦ 17:30~18:30 Poster Presentation  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2022-07-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¤½ÅÀÇÇÐ ÃÖ½ÅÁö°ß(Ç׿ì¿ïÁ¦¿Í ¼ö¸é, Æ÷½ºÆ® Äڷγª¿Í Áø·á½Ç¿¡ ÈçÈ÷ ¸¸³ª´Â Á¤½ÅÁúȯ) : 2022-07-07
´ÙÀ½±Û ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ(¹Ì¼÷¾Æ Áö¼Ó°ü¸®, ÅÂ¾Æ ³ú ±âÇüÀÇ »êÀü ÃÊÀ½ÆÄ ¼Ò°ß) : 2022-07-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
504 ¼­¿ï 2018³â Á¦ 9ȸ ¼­¿ï¾Æ»êº´¿ø ±¹¸³º¸°Ç¿¬±¸¿ø ¾Ë·¹¸£±âÁúȯ ¿ªÇÐ ½ÉÆ÷Áö¾ö : 2018-09-08 0 652 2018-08-22
503 °æ³² â¿ø °æ»ó´ëÇб³º´¿ø °æ³²°³¿ø³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 1,362 2018-08-22
502 ±¤ÁÖ Á¦169Â÷ ´ëÇѼҾưúÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2018-09-08 0 900 2018-08-22
501 ¼­¿ï °¡Å縯ÀÇ´ë(¼­¿ï¼º¸ðº´¿ø) 2018 ´ëÇÑ°¨¿°ÇÐȸ Àü°øÀÇ¿Í Àü¹®ÀǸ¦ À§ÇÑ Ãß°è °¨¿°ÇÐ ¿¬¼ö°­Á : 2018-09-08 0 468 2018-08-22
500 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À¯¹æ¼ºÇü¿¬±¸È¸ 3Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 1 822 2018-08-22
499 ºÎ»ê Á¦7ȸ ºÎ¹Îº´¿ø ½½°üÀý ½ÉÆ÷Áö¾ö(´ëÇѽ½°üÀýÇÐȸ, ºÎ¹Îº´¿ø °øµ¿ÁÖ°ü) : 2018-09-08 0 1,555 2018-08-22
498 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø 2018 ¾Æ»ê ÇÙÀÇÇÐ ½ÉÆ÷Áö¾ö : 2018-09-08 0 592 2018-08-22
497 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 KYUNG HEE SHOULDER SYMPOSIUM : 2018-09-08 0 1,500 2018-08-22
496 ´ë±¸ °æºÏ´ëÇб³º´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-07 0 740 2018-08-22
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 917 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,003 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 793 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 616 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 713 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 983 2018-08-22
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷